BVS vs USB · rev $573.3M vs P/E 12, rev $28.66B
Bioventus Inc (BVS) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
BVS currently screens at market cap $495.1M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the BVS and USB stock pages for the full models.
Not investment advice.